Showing results (51-60 of 745) with videos related to

Sort By:
Pageof 75
Neurologia|June 8, 2017
Systemic Th17/IL-17A response appears prior to hippocampal neurodegeneration in rats exposed to low doses of ozoneH Solleiro-Villavicencio, S Rivas-Arancibia
Neurologia|April 12, 2018
Biomarkers of Alzheimer's disease in mild cognitive impairment: Experience in a memory clinic from Latin AmericaR F Allegri, P Chrem Mendez, M J Russo, et al.
Neurologia|September 21, 2016
Variability and trends in the consumption of drugs for treating attention-deficit/hyperactivity disorder in Castile-La Mancha, Spain (1992-2015)J J Criado-Álvarez, J González González, C Romo Barrientos, et al.
Neurologia|April 30, 2017
Brain disease, connectivity, plasticity and cognitive therapy: A neurological view of mental disordersG Lubrini, A Martín-Montes, O Díez-Ascaso, et al.
Neurologia|April 14, 2023
Incidence and prevalence of multiple sclerosis in China and other Asian countriesG X Zhang, A Carrillo-Vico, W T Zhang, et al.
Neurologia|April 21, 2023
Prevalence of neurological complications in infective endocarditisJ Rodríguez-Montolio, D Meseguer-Gonzalez, M Almeida-Zurita, et al.
Neurologia|April 8, 2023
Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headacheD García-Azorín, J Abelaira-Freire, E Rodriguez-Adrada, et al.
Neurologia|July 12, 2020
Endovascular embolisation of the middle meningeal artery to treat chronic subdural haematomas: Effectiveness, safety, and the current controversy. A systematic reviewR Martinez-Perez, N Rayo, A Tsimpas
Neurologia|April 28, 2023
Botulinum toxin type A infiltration in spasticity and cervical dystonia. Muscle morphology: an overlooked factorM Murie-Fernández, C Bahamonde, D Graffigna, et al.
Neurologia|April 28, 2023
Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA studyJ E Meca-Lallana, J C Álvarez-Cermeño, B Casanova Estruch, et al.
Pageof 75